You think the share price will rise exponentially based on a 7 person safety trial?
We have already pumped people full of the drug intravenously, swish/spit with a mouth rinse, and with a retention enema.
The question isn't whether B is safe, but rather, is the drug effective for UC and can they deliver it where it is needed in the proper quantity?
Failure in phase 1 tanks the company.
Success in phase 1 means we need to find more funding for a phase 2 which equates to more selling pressure on the stock absent a deal due to fund raising.
Go IPIX!